vs
Bionano Genomics, Inc.（BNGO）与EyePoint, Inc.（EYPT）财务数据对比。点击上方公司名可切换其他公司
Bionano Genomics, Inc.的季度营收约是EyePoint, Inc.的12.8倍（$8.0M vs $619.0K）。Bionano Genomics, Inc.净利率更高（-99.8% vs -10922.3%，领先10822.5%）。Bionano Genomics, Inc.同比增速更快（-2.6% vs -94.7%）。过去两年Bionano Genomics, Inc.的营收复合增速更高（-4.8% vs -77.0%）
Bionano Genomics是一家基因组技术企业，开发并销售专有光学基因组测绘技术及相关诊断解决方案，可高精度检测基因组大型结构变异，服务全球学术研究机构、生物制药企业与临床诊断实验室，产品应用于肿瘤、罕见病研究等领域。
EyePoint制药公司总部位于马萨诸塞州沃特敦，是一家专注于将微机电系统（MEMS）与纳米技术应用于给药领域的专业医药企业，依托前沿交叉技术开发创新给药方案，聚焦眼科等领域的药物递送技术创新与产品开发。
BNGO vs EYPT — 直观对比
营收规模更大
BNGO
是对方的12.8倍
$619.0K
营收增速更快
BNGO
高出92.1%
-94.7%
净利率更高
BNGO
高出10822.5%
-10922.3%
两年增速更快
BNGO
近两年复合增速
-77.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $8.0M | $619.0K |
| 净利润 | $-7.9M | $-67.6M |
| 毛利率 | 42.8% | — |
| 营业利润率 | -107.4% | -11364.3% |
| 净利率 | -99.8% | -10922.3% |
| 营收同比 | -2.6% | -94.7% |
| 净利润同比 | 60.6% | -63.3% |
| 每股收益（稀释后） | $-0.12 | $-0.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BNGOEYPT
| Q4 25 | $8.0M | $619.0K | ||
| Q3 25 | $7.4M | $966.0K | ||
| Q2 25 | $6.7M | $5.3M | ||
| Q1 25 | $6.5M | $24.5M | ||
| Q4 24 | $8.2M | $11.6M | ||
| Q3 24 | $6.1M | $10.5M | ||
| Q2 24 | $7.8M | $9.5M | ||
| Q1 24 | $8.8M | $11.7M |
净利润BNGOEYPT
| Q4 25 | $-7.9M | $-67.6M | ||
| Q3 25 | $-8.5M | $-59.7M | ||
| Q2 25 | $-6.9M | $-59.4M | ||
| Q1 25 | $-3.1M | $-45.2M | ||
| Q4 24 | $-20.1M | $-41.4M | ||
| Q3 24 | $-44.2M | $-29.4M | ||
| Q2 24 | $-16.2M | $-30.8M | ||
| Q1 24 | $-31.4M | $-29.3M |
毛利率BNGOEYPT
| Q4 25 | 42.8% | — | ||
| Q3 25 | 45.7% | — | ||
| Q2 25 | 51.6% | — | ||
| Q1 25 | 45.5% | — | ||
| Q4 24 | 41.9% | — | ||
| Q3 24 | -139.1% | 93.0% | ||
| Q2 24 | 33.3% | 85.2% | ||
| Q1 24 | 32.2% | 93.5% |
营业利润率BNGOEYPT
| Q4 25 | -107.4% | -11364.3% | ||
| Q3 25 | -115.9% | -6420.8% | ||
| Q2 25 | -115.8% | -1166.8% | ||
| Q1 25 | -131.1% | -199.7% | ||
| Q4 24 | -146.3% | -390.4% | ||
| Q3 24 | -722.9% | -311.2% | ||
| Q2 24 | -219.0% | -364.5% | ||
| Q1 24 | -354.9% | -285.2% |
净利率BNGOEYPT
| Q4 25 | -99.8% | -10922.3% | ||
| Q3 25 | -115.4% | -6183.4% | ||
| Q2 25 | -101.8% | -1114.3% | ||
| Q1 25 | -48.0% | -184.8% | ||
| Q4 24 | -246.5% | -357.3% | ||
| Q3 24 | -728.6% | -279.0% | ||
| Q2 24 | -208.8% | -325.3% | ||
| Q1 24 | -358.3% | -250.6% |
每股收益（稀释后）BNGOEYPT
| Q4 25 | $-0.12 | $-0.82 | ||
| Q3 25 | $-1.59 | $-0.85 | ||
| Q2 25 | $-1.99 | $-0.85 | ||
| Q1 25 | $-1.15 | $-0.65 | ||
| Q4 24 | $-7.05 | $-0.65 | ||
| Q3 24 | $-30.92 | $-0.54 | ||
| Q2 24 | $-14.41 | $-0.58 | ||
| Q1 24 | $-35.75 | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $3.0M | $306.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $44.4M | $306.1M |
| 总资产 | $73.6M | $364.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BNGOEYPT
| Q4 25 | $3.0M | $306.1M | ||
| Q3 25 | $3.1M | $204.0M | ||
| Q2 25 | $3.6M | $255.7M | ||
| Q1 25 | $3.6M | $318.2M | ||
| Q4 24 | $9.2M | $370.9M | ||
| Q3 24 | $8.8M | $253.8M | ||
| Q2 24 | $10.4M | $280.2M | ||
| Q1 24 | $15.8M | $299.3M |
股东权益BNGOEYPT
| Q4 25 | $44.4M | $306.1M | ||
| Q3 25 | $49.8M | $200.2M | ||
| Q2 25 | $45.4M | $246.0M | ||
| Q1 25 | $48.2M | $298.4M | ||
| Q4 24 | $35.4M | $336.5M | ||
| Q3 24 | $48.9M | $218.7M | ||
| Q2 24 | $80.3M | $228.3M | ||
| Q1 24 | $82.8M | $249.9M |
总资产BNGOEYPT
| Q4 25 | $73.6M | $364.0M | ||
| Q3 25 | $79.1M | $251.7M | ||
| Q2 25 | $76.0M | $301.1M | ||
| Q1 25 | $78.4M | $362.6M | ||
| Q4 24 | $76.7M | $418.5M | ||
| Q3 24 | $87.4M | $300.9M | ||
| Q2 24 | $129.4M | $324.2M | ||
| Q1 24 | $158.0M | $329.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-4.2M | $-65.0M |
| 自由现金流经营现金流 - 资本支出 | — | $-66.0M |
| 自由现金流率自由现金流/营收 | — | -10667.7% |
| 资本支出强度资本支出/营收 | — | 159.3% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-243.4M |
8季度趋势，按日历期对齐
经营现金流BNGOEYPT
| Q4 25 | $-4.2M | $-65.0M | ||
| Q3 25 | $-5.9M | $-59.4M | ||
| Q2 25 | $-3.5M | $-62.6M | ||
| Q1 25 | $-2.8M | $-53.1M | ||
| Q4 24 | $-6.5M | $-35.8M | ||
| Q3 24 | $-13.3M | $-39.0M | ||
| Q2 24 | $-21.0M | $-20.2M | ||
| Q1 24 | $-28.1M | $-31.2M |
自由现金流BNGOEYPT
| Q4 25 | — | $-66.0M | ||
| Q3 25 | — | $-60.2M | ||
| Q2 25 | — | $-63.8M | ||
| Q1 25 | — | $-53.4M | ||
| Q4 24 | — | $-36.2M | ||
| Q3 24 | — | $-40.6M | ||
| Q2 24 | — | $-21.1M | ||
| Q1 24 | — | $-32.4M |
自由现金流率BNGOEYPT
| Q4 25 | — | -10667.7% | ||
| Q3 25 | — | -6226.9% | ||
| Q2 25 | — | -1196.5% | ||
| Q1 25 | — | -218.4% | ||
| Q4 24 | — | -312.7% | ||
| Q3 24 | — | -385.8% | ||
| Q2 24 | — | -222.4% | ||
| Q1 24 | — | -277.0% |
资本支出强度BNGOEYPT
| Q4 25 | — | 159.3% | ||
| Q3 25 | — | 82.6% | ||
| Q2 25 | — | 22.9% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 15.0% | ||
| Q2 24 | — | 9.5% | ||
| Q1 24 | — | 10.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
